TLR3- and MyD88-Dependent Signaling Differentially Influences the Development of West Nile Virus-Specific B Cell Responses in Mice following Immunization with RepliVAX WN, a Single-Cycle Flavivirus Vaccine Candidate

Cutting Edge: Cooperation of IPS-1- and TRIF-Dependent Pathways in Poly IC-Enhanced Antibody Production and Cytotoxic T Cell Responses

(2014) H. Kumar et al.   JOURNAL OF IMMUNOLOGY

Toll-Like Receptor Expression and Induction of Type I and Type III Interferons in Primary Airway Epithelial Cells

(2013) I. Ioannidis et al.   JOURNAL OF VIROLOGY

B cell TLRs and induction of immunoglobulin class-switch DNA recombination

(2012) Egest et al.   Frontiers in Bioscience-Landmark

Nucleic Acid-Sensing Toll-like Receptors Are Essential for the Control of Endogenous Retrovirus Viremia and ERV-Induced Tumors

(2012) Philipp Yu et al.   IMMUNITY

Germinal center selection and the development of memory B and plasma cells

(2012) Mark J. Shlomchik et al.   IMMUNOLOGICAL REVIEWS

Modulation of dendritic cell function and immune response by cysteine protease inhibitor from murine nematode parasiteHeligmosomoides polygyrus

(2012) Yanxia Sun et al.   IMMUNOLOGY

Multiple routes to B-cell memory

(2012) K. L. Good-Jacobson et al.   INTERNATIONAL IMMUNOLOGY

TLR7 Recognition Is Dispensable for Influenza Virus A Infection but Important for the Induction of Hemagglutinin-Specific Antibodies in Response to the 2009 Pandemic Split Vaccine in Mice

(2012) V. Jeisy-Scott et al.   JOURNAL OF VIROLOGY

Intrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signaling

(2012) Evandro R. Winkelmann et al.   VACCINE

Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in mice

(2012) Joanne M. Lumsden et al.   VACCINE

Plasmacytoid Dendritic Cells Are Crucial for the Initiation of Inflammation and T Cell Immunity In Vivo

(2011) Hideaki Takagi et al.   IMMUNITY

Selective Utilization of Toll-like Receptor and MyD88 Signaling in B Cells for Enhancement of the Antiviral Germinal Center Response

(2011) Baidong Hou et al.   IMMUNITY

Poorly Neutralizing Cross-Reactive Antibodies against the Fusion Loop of West Nile Virus Envelope Protein Protect In Vivo via Fc  Receptor and Complement-Dependent Effector Mechanisms

(2011) M. R. Vogt et al.   JOURNAL OF VIROLOGY

CD8+ T Cell Immunodominance in Lymphocytic Choriomeningitis Virus Infection Is Modified in the Presence of Toll-Like Receptor Agonists

(2011) S. Siddiqui et al.   JOURNAL OF VIROLOGY

MyD88 Plays an Essential Role in Inducing B Cells Capable of Differentiating into Antibody-Secreting Cells after Vaccination

(2011) S.-M. Kang et al.   JOURNAL OF VIROLOGY

Toll-Like Receptor Agonists Synergize with CD40L to Induce Either Proliferation or Plasma Cell Differentiation of Mouse B Cells

(2011) Emmanuelle Boeglin et al.   PLoS One

Toll-like Receptor 7 Controls the Anti-Retroviral Germinal Center Response

(2011) Edward P. Browne   PLoS Pathogens

Evaluation of RepliVAX WN, a Single-Cycle Flavivirus Vaccine, in a Non-Human Primate Model of West Nile Virus Infection

(2010) Douglas G. Widman et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Signaling via the MyD88 Adaptor Protein in B Cells Suppresses Protective Immunity during Salmonella typhimurium Infection

(2010) Patricia Neves et al.   IMMUNITY

Recognition by toll-like receptor 2 induces antigen-presenting cell activation and Th1 programming during infection by Neospora caninum

(2010) Tiago WP Mineo et al.   IMMUNOLOGY AND CELL BIOLOGY

Low-valency, but not monovalent, antigens trigger the B-cell antigen receptor (BCR)

(2010) S. Minguet et al.   INTERNATIONAL IMMUNOLOGY

Type I IFN enhances follicular B cell contribution to the T cell–independent antibody response

(2010) Cristina L. Swanson et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Cutting Edge: IL-21 and TLR Signaling Regulate Germinal Center Responses in a B Cell-Intrinsic Manner

(2010) J. Bessa et al.   JOURNAL OF IMMUNOLOGY

Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Immunogenicity and Safety of a West Nile Virus Vaccine in Healthy Adults

(2010) Rex Biedenbender et al.   JOURNAL OF INFECTIOUS DISEASES

Human IgG Subclasses: In Vitro Neutralization of and In Vivo Protection against West Nile Virus

(2010) Y. Hofmeister et al.   JOURNAL OF VIROLOGY

The Innate Immune Adaptor Molecule MyD88 Restricts West Nile Virus Replication and Spread in Neurons of the Central Nervous System

(2010) K. J. Szretter et al.   JOURNAL OF VIROLOGY

Development and evaluation of a formalin-inactivated West Nile Virus vaccine (WN-VAX) for a human vaccine candidate

(2010) Guillermo Posadas-Herrera et al.   VACCINE

Immunogenicity of RepliVAX WN, a novel single-cycle West Nile virus vaccine

(2010) Michelle H. Nelson et al.   VACCINE

Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice

(2010) Matthew D Dunn et al.   Virology Journal

Toll-like Receptor and RIG-1-like Receptor Signaling

(2009) Taro Kawai et al.   Annals of the New York Academy of Sciences

RepliVAX WN, a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamsters

(2009) Douglas G. Widman et al.   VACCINE

Enhanced B-cell activation mediated by TLR4 and BCR crosstalk

(2008) Susana Minguet et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

The structural immunology of antibody protection against West Nile virus

(2008) Michael S. Diamond et al.   IMMUNOLOGICAL REVIEWS

GABPβ2 Is Dispensible for Normal Lymphocyte Development but Moderately Affects B Cell Responses

(2008) Xuefang Jing et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Role for MyD88 Signaling in Murine Gammaherpesvirus 68 Latency

(2008) L. M. Gargano et al.   JOURNAL OF VIROLOGY

Construction and Characterization of a Single-Cycle Chimeric Flavivirus Vaccine Candidate That Protects Mice against Lethal Challenge with Dengue Virus Type 2

(2008) R. Suzuki et al.   JOURNAL OF VIROLOGY

Early B-Cell Activation after West Nile Virus Infection Requires Alpha/Beta Interferon but Not Antigen Receptor Signaling

(2008) W. E. Purtha et al.   JOURNAL OF VIROLOGY

Toll-Like Receptor 3 Has a Protective Role against West Nile Virus Infection

(2008) S. Daffis et al.   JOURNAL OF VIROLOGY

Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

(2008) Maria Florencia Delgado et al.   NATURE MEDICINE

Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system

(2008) Douglas G. Widman et al.   VACCINE

West Nile virus genome amplification requires the functional activities of the proteasome

(2008) Felicia Gilfoy et al.   VIROLOGY